🔎 Trials Near Me

Home › Leukemia › NCT02560883

Hairy Cell Leukemia Patient Data Registry

RecruitingObservational study

Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion:

* Patients with classic hairy cell leukemia
* Patients with the variant of hairy cell leukemia.

Exclusion:

* Children are excluded from the study, since Hairy Cell Leukemia wasn't described in children.

About the study

The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of this rare disease identified in the US each year, HCL represents 2% of all cases of leukemia in adults. Considering the rarity of this chronic leukemia, the Hairy Cell Leukemia Foundation (HCLF), in partnership with investigators from its Centers of Excellence, seeks to develop a registry to help researchers identify new trends in outcomes, recognize the most effective treatments, discover previously unknown complications of the disease, and design clinical trials for new therapies.

Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 5,000 · Started: Jan 2, 2013

Contact the study team

Official record on ClinicalTrials.gov — NCT02560883

Locations in the U.S.

FloridaUniversity of Miami/Soffer Clinical Research Center, Miami
Mount Sinai Medical Center of Florida, Miami Beach
MinnesotaMayo Clinic, Rochester
New YorkUniversity of Rochester /Wilmot Cancer Institute, Rochester
OhioOhio State University Comprehensive Cancer Center, Columbus

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.